Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
prostate cancer | ACP3* | Acp3* | 1 model | Alliance of Genome Resources | |||
prostate cancer | APC* | Apc* | 1 model | Alliance of Genome Resources | |||
prostate cancer | PTEN* | Pten* | 20 models | Alliance of Genome Resources | |||
prostate cancer | CTNNB1 | Ctnnb1* | 2 models | Alliance of Genome Resources | |||
prostate cancer | KRAS | Kras* | 4 models | Alliance of Genome Resources | |||
prostate cancer | MSMB | Msmb* | 1 model | Alliance of Genome Resources | |||
prostate cancer | NKX3-1 | Nkx3-1* | 7 models | Alliance of Genome Resources | |||
prostate cancer | TGFBR2 | Tgfbr2* | 1 model | Alliance of Genome Resources | |||
castration-resistant prostate carcinoma | CCNE2* | Ccne2 | Alliance of Genome Resources | ||||
castration-resistant prostate carcinoma | NUF2* | Nuf2 | Alliance of Genome Resources | ||||
castration-resistant prostate carcinoma | CHD1* | Chd1 | Alliance of Genome Resources | ||||
prostate adenocarcinoma | STAT1* | Stat1 | Alliance of Genome Resources | ||||
prostate adenocarcinoma | RAF1* | Raf1 | Alliance of Genome Resources | ||||
prostate adenocarcinoma | PIK3CB* | Pik3cb | Alliance of Genome Resources | ||||
prostate adenocarcinoma | NCOA2* | Ncoa2 | Alliance of Genome Resources | ||||
prostate adenocarcinoma | MAPK1* | Mapk1 | Alliance of Genome Resources | ||||
prostate adenocarcinoma | INSR* | Insr | Alliance of Genome Resources | ||||
prostate adenocarcinoma | IKBKB* | Ikbkb | Alliance of Genome Resources | ||||
prostate adenocarcinoma | IGF1R* | Igf1r | Alliance of Genome Resources | ||||
prostate adenocarcinoma | GRB2* | Grb2 | Alliance of Genome Resources | ||||
prostate adenocarcinoma | FGF2* | Fgf2 | Alliance of Genome Resources | ||||
prostate adenocarcinoma | CD9* | Cd9 | Alliance of Genome Resources | ||||
prostate adenocarcinoma | ADIPOQ* | Adipoq | Alliance of Genome Resources | ||||
prostate adenocarcinoma | ADIPOR1* | Adipor1 | Alliance of Genome Resources | ||||
prostate adenocarcinoma | AKT1* | Akt1 | Alliance of Genome Resources | ||||
prostate adenocarcinoma | AKT2* | Akt2 | Alliance of Genome Resources | ||||
prostate adenocarcinoma | AKT3* | Akt3 | Alliance of Genome Resources | ||||
prostate adenocarcinoma | BIN1* | Bin1 | Alliance of Genome Resources | ||||
prostate adenocarcinoma | MYC* | Bmyc, Myc | Alliance of Genome Resources | ||||
prostate adenocarcinoma | BRAF* | Braf | Alliance of Genome Resources | ||||
prostate adenocarcinoma | CAMK2N1* | Camk2n1 | Alliance of Genome Resources | ||||
prostate cancer | CAV1* | Cav1 | Alliance of Genome Resources | ||||
prostate cancer | CCNA1* | Ccna1 | Alliance of Genome Resources | ||||
prostate cancer | CCNB1* | Ccnb1, Ccnb1-ps | Alliance of Genome Resources | ||||
prostate cancer | CCND2* | Ccnd2 | Alliance of Genome Resources | ||||
prostate cancer | CD44* | Cd44 | Alliance of Genome Resources | ||||
prostate cancer | CD55* | Cd55, Cd55b | Alliance of Genome Resources | ||||
prostate cancer | CDC25A* | Cdc25a | Alliance of Genome Resources | ||||
prostate cancer | CDC25C* | Cdc25c | Alliance of Genome Resources | ||||
prostate cancer | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
prostate cancer | CDH13* | Cdh13 | Alliance of Genome Resources | ||||
prostate cancer | CDK2* | Cdk2 | Alliance of Genome Resources | ||||
prostate cancer | CDK4* | Cdk4 | Alliance of Genome Resources | ||||
prostate cancer | CDKN2A* | Cdkn2a | 1 model | Alliance of Genome Resources | |||
prostate cancer | CHD1* | Chd1 | Alliance of Genome Resources | ||||
prostate cancer | CHEK2* | Chek2 | Alliance of Genome Resources | ||||
prostate cancer | CHGA* | Chga | Alliance of Genome Resources | ||||
prostate cancer | CHUK* | Chuk | Alliance of Genome Resources | ||||
prostate cancer | COMT* | Comt | Alliance of Genome Resources | ||||
prostate cancer | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
prostate cancer | CYP17A1* | Cyp17a1 | Alliance of Genome Resources | ||||
prostate cancer | DAB2IP* | Dab2ip | Alliance of Genome Resources | ||||
prostate cancer | EGFR* | Egfr | Alliance of Genome Resources | ||||
prostate cancer | EIF3H* | Eif3h | Alliance of Genome Resources | ||||
prostate cancer | ENO2* | Eno2 | Alliance of Genome Resources | ||||
prostate cancer | EPHB1* | Ephb1 | Alliance of Genome Resources | ||||
prostate cancer | ERBB2* | Erbb2 | Alliance of Genome Resources | ||||
prostate cancer | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
prostate cancer | ESR1* | Esr1 | Alliance of Genome Resources | ||||
prostate cancer | ESR2* | Esr2 | Alliance of Genome Resources | ||||
prostate cancer | FAS* | Fas | Alliance of Genome Resources | ||||
prostate cancer | FGFR4* | Fgfr4 | Alliance of Genome Resources | ||||
prostate cancer | FHIT* | Fhit | Alliance of Genome Resources | ||||
prostate cancer | FLT3* | Flt3 | Alliance of Genome Resources | ||||
prostate cancer | GRB2* | Grb2 | Alliance of Genome Resources | ||||
prostate cancer | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
prostate cancer | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
prostate cancer | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
prostate cancer | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
prostate cancer | HIF1A* | Hif1a | Alliance of Genome Resources | ||||
prostate cancer | ICAM1* | Icam1 | Alliance of Genome Resources | ||||
prostate cancer | IGFBP3* | Igfbp3 | Alliance of Genome Resources | ||||
prostate cancer | IKBKB* | Ikbkb | Alliance of Genome Resources | ||||
prostate cancer | IL16* | Il16 | Alliance of Genome Resources | ||||
prostate cancer | JAK1* | Jak1 | Alliance of Genome Resources | ||||
prostate cancer | JUP* | Jup | Alliance of Genome Resources | ||||
prostate cancer | KIF5A* | Kif5a | Alliance of Genome Resources | ||||
prostate cancer | KLF6* | Klf6 | Alliance of Genome Resources | ||||
prostate cancer | KLK4* | Klk4 | Alliance of Genome Resources | ||||
prostate cancer | KLK10* | Klk10 | Alliance of Genome Resources | ||||
prostate cancer | LIG4* | Lig4 | Alliance of Genome Resources | ||||
prostate cancer | LINC01595* | ||||||
prostate cancer | MAD1L1* | Mad1l1 | Alliance of Genome Resources | ||||
prostate cancer | MAP3K7* | Map3k7 | Alliance of Genome Resources | ||||
prostate cancer | MIR615* | Mir615 | Alliance of Genome Resources | ||||
prostate cancer | MSR1* | Msr1 | Alliance of Genome Resources | ||||
prostate cancer | MTOR* | Mtor | Alliance of Genome Resources | ||||
prostate cancer | MX1*, MX2 | Mx1, Mx2 | Alliance of Genome Resources | ||||
prostate cancer | MXI1* | Mxi1 | Alliance of Genome Resources | ||||
prostate cancer | NAT1*, NAT2* | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
prostate cancer | NBN* | Nbn | Alliance of Genome Resources | ||||
prostate cancer | NFKB1* | Nfkb1 | Alliance of Genome Resources | ||||
prostate cancer | NFKBIA* | Nfkbia | Alliance of Genome Resources | ||||
prostate cancer | NOS3* | Nos3 | Alliance of Genome Resources | ||||
prostate cancer | OGG1* | Ogg1 | Alliance of Genome Resources | ||||
prostate cancer | PEBP1* | Pbp2, Pebp1 | Alliance of Genome Resources | ||||
prostate cancer | PDPK1*, PDPK2P | Pdpk1 | Alliance of Genome Resources | ||||
prostate cancer | PIK3CB* | Pik3cb | Alliance of Genome Resources | ||||
prostate cancer | PTGS2* | Ptgs2 | Alliance of Genome Resources | ||||
prostate cancer | RASSF1* | Rassf1 | Alliance of Genome Resources | ||||
prostate cancer | RB1* | Rb1 | Alliance of Genome Resources | ||||
prostate cancer | RNASEL* | Rnasel | Alliance of Genome Resources | ||||
prostate cancer | RTEL1* | Rtel1 | Alliance of Genome Resources | ||||
prostate cancer | SOCS1* | Socs1 | Alliance of Genome Resources | ||||
prostate cancer | SRC* | Src | Alliance of Genome Resources | ||||
prostate cancer | SRD5A1* | Srd5a1 | Alliance of Genome Resources | ||||
prostate cancer | SRD5A2* | Srd5a2 | Alliance of Genome Resources | ||||
prostate cancer | SREBF2* | Srebf2 | Alliance of Genome Resources | ||||
prostate cancer | STAT3* | Stat3 | Alliance of Genome Resources | ||||
prostate cancer | SULT1A1*, SULT1A2, SULT1A3, SULT1A4 | Sult1a1 | Alliance of Genome Resources | ||||
prostate cancer | SULT2A1* | Sult2a1, Sult2a2, Sult2a3, Sult2a4, Sult2a5, Sult2a6, Sult2a7, Sult2a8 | Alliance of Genome Resources | ||||
prostate cancer | TCF7L2* | Tcf7l2 | Alliance of Genome Resources | ||||
prostate cancer | TERC* | ||||||
prostate cancer | THRB* | Thrb | Alliance of Genome Resources | ||||
prostate cancer | TLR2* | Tlr2 | Alliance of Genome Resources | ||||
prostate cancer | TMEFF2* | Tmeff2 | Alliance of Genome Resources | ||||
prostate cancer | TNF* | Tnf | Alliance of Genome Resources | ||||
prostate cancer | TP53* | Trp53 | 2 models | Alliance of Genome Resources | |||
prostate cancer | TSG101* | Tsg101 | Alliance of Genome Resources | ||||
prostate cancer | TSPY1* | ||||||
prostate cancer | VDAC1* | Vdac1 | Alliance of Genome Resources | ||||
prostate cancer | VDR* | Vdr | Alliance of Genome Resources | ||||
prostate cancer | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
prostate cancer | XIAP*, BIRC8 | Xiap | Alliance of Genome Resources | ||||
prostate cancer | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
prostate cancer | ZFHX3* | Zfhx3 | Alliance of Genome Resources | ||||
prostate cancer | CXCR4* | Cxcr4 | Alliance of Genome Resources | ||||
prostate cancer | ACSL3* | Acsl3 | Alliance of Genome Resources | ||||
prostate cancer | AGAP2* | Agap2 | Alliance of Genome Resources | ||||
prostate cancer | AKT1* | Akt1 | Alliance of Genome Resources | ||||
prostate cancer | AKT2* | Akt2 | Alliance of Genome Resources | ||||
prostate cancer | AKT3* | Akt3 | Alliance of Genome Resources | ||||
prostate cancer | ANG* | Ang, Ang2, Ang3, Ang4, Ang5, Ang6 | Alliance of Genome Resources | ||||
prostate cancer | AR* | Ar | 4 models | Alliance of Genome Resources | |||
prostate cancer | BAG1* | Bag1 | Alliance of Genome Resources | ||||
prostate cancer | BCL2* | Bcl2 | Alliance of Genome Resources | ||||
prostate cancer | BGLAP* | Bglap, Bglap2, Bglap3 | Alliance of Genome Resources | ||||
prostate cancer | BIK* | Bik | Alliance of Genome Resources | ||||
prostate cancer | BIRC5* | Birc5 | Alliance of Genome Resources | ||||
prostate cancer | BMP2* | Bmp2 | Alliance of Genome Resources | ||||
prostate cancer | BMP7* | Bmp7 | Alliance of Genome Resources | ||||
prostate cancer | MYC* | Bmyc, Myc | Alliance of Genome Resources | ||||
prostate cancer | BRCA1* | Brca1 | Alliance of Genome Resources | ||||
prostate cancer | BRCA2* | Brca2 | 1 model | Alliance of Genome Resources | |||
prostate cancer | CADM1* | Cadm1 | Alliance of Genome Resources | ||||
prostate carcinoma | CDK13* | Cdk13 | Alliance of Genome Resources | ||||
prostate carcinoma | BCL2L1* | Bcl2l1 | Alliance of Genome Resources | ||||
prostate carcinoma | ATF4* | Atf4 | Alliance of Genome Resources | ||||
prostate carcinoma | AKT2* | Akt2 | Alliance of Genome Resources | ||||
prostate carcinoma | STAT6* | Stat6 | Alliance of Genome Resources | ||||
prostate carcinoma | STAT3* | Stat3 | Alliance of Genome Resources | ||||
prostate carcinoma | SPP1* | Spp1 | Alliance of Genome Resources | ||||
prostate carcinoma | SKP2* | Skp2 | Alliance of Genome Resources | ||||
prostate carcinoma | PRKCA* | Prkca | Alliance of Genome Resources | ||||
prostate carcinoma | INHA* | Inha | Alliance of Genome Resources | ||||
prostate carcinoma | EIF3H* | Eif3h | Alliance of Genome Resources | ||||
prostate carcinoma | E2F5* | E2f5 | Alliance of Genome Resources | ||||
prostate carcinoma | AZGP1* | Azgp1 | Alliance of Genome Resources | ||||
prostate carcinoma in situ | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
prostate carcinoma in situ | FGF8* | Fgf8 | Alliance of Genome Resources | ||||
prostatic hypertrophy | SRD5A1* | Srd5a1 | Alliance of Genome Resources | ||||
prostatic hypertrophy | PDGFD* | Pdgfd | Alliance of Genome Resources | ||||
prostatic hypertrophy | PDGFB* | Pdgfb | Alliance of Genome Resources | ||||
prostatitis | CYP19A1* | Cyp19a1 | Alliance of Genome Resources |
Transgenes and other genome features developed in mice to model this disease.
|
|||
Disease Term | Transgenes and Other Genome Features | Mouse Models | |
prostate adenocarcinoma | Tg(Pbsn-Tag)12T10Rjm | 1 model | |
prostate cancer | Tg(ARR2/Pbsn-MYC)7Key | 1 model | |
prostate cancer | Tg(C3-1-TAg)cJeg | 1 model | |
prostate cancer | Tg(Ggamma-T)15Cps | 2 models | |
prostate cancer | Tg(Msmb-TAg)183-2Xuan | 1 model | |
prostate cancer | Tg(Msmb-TAg)186-3Xuan | 1 model | |
prostate cancer | Tg(Pbsn-Ar*E231G)7353Ng | 1 model | |
prostate cancer | Tg(Pbsn-ERG*)1Vv | 1 model | |
prostate cancer | Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp | 2 models | |
prostate cancer | Tg(Pbsn-MYC)6Key | 1 model | |
prostate cancer | Tg(Pbsn-MYC)#Tt | 1 model | |
prostate cancer | Tg(Pbsn-Tag)12T7fRjm | 1 model | |
prostate cancer | Tg(Pbsn-TAg)15Tvd | 2 models | |
prostate cancer | Tg(TRAMP)8247Ng | 6 models |